Abstract The purpose of this paper is to review the evidence for the role of physical rehabilitation in stem cell transplantation patients. We will also review the literature and discuss professional experiences on how rehabilitation can play a role in stem cell transplant care and survivorship. Hematopoietic stem cell transplantation (HCT) is a procedure that has evolved substantially over the years to help treat multiple conditions, particularly hematologic malignancies. HCT can be very stressful on the body and can leave patients weakened and sometimes quite debilitated. Supportive care measures have advanced to improve the quality of life and overall survival of HCT survivors. One key component of improved supportive care is gaining increased attention, and that is physical medicine and rehabilitation. Its role in HCT survivorship care is expanding, and new insight and research within the discipline have focused on fatigue, inflammation, exercise, and the development of structured rehabilitation programs to improve the musculoskeletal sequelae of transplantation. This literature review has demonstrated the utility of physical rehabilitation in HCT, its impact on cancer-related fatigue, and to outline the current state of the literature on these topics. The paper delves into a background of HCT. Cancer-related fatigue in HCT is then discussed and summarized, and the role that exercise plays in modifying such fatigue is outlined. We then outline the models and the impact that physical rehabilitation may play in HCT recipients.
Introduction
Hematopoietic stem cell transplantation (HCT) is a procedure that has evolved substantially over the years to help treat multiple conditions, particularly hematologic malignancies. HCT can be very stressful on the body and often leaves patients weakened and quite debilitated. Supportive care measures have advanced to improve the quality of life and overall survival of HCT patients. Physical medicine and rehabilitation is gaining increased attention and is one key component of improved supportive care. New insight and research within the discipline have focused on fatigue, inflammation, exercise, and the development of structured rehabilitation programs to improve the musculoskeletal sequelae of HCT. The primary purpose of this review is to demonstrate the utility of physical rehabilitation in HCT, its impact on cancer-related fatigue, and to outline the current state of the literature on these topics. The paper first discusses the background of HCT. Cancer-related fatigue in HCT is then discussed and summarized, and the role that exercise plays in modifying such fatigue is outlined. We then outline the models and the impact that physical rehabilitation may play in HCT recipients.
Stem cell transplantation
HCT is a procedure used to treat and potentially cure a number of medical conditions, including leukemia, lymphoma, and myeloma, and inherited conditions such as thalassemia and sickle cell anemia. HCT was first described in humans in the medical literature in 1957 [1] . Generally, HCT may be broken down into autologous transplants or allogeneic transplants.
In autologous transplantation, a patient's stem cells (which have the potential to differentiate into new white cells, red blood cells, and platelets) are collected prior to high-dose chemotherapy. High-dose chemotherapy is then administered to destroy neoplastic cells. The high-dose chemotherapy damages the patients' ability to produce blood cells. This is rectified by reintroducing the previously collected stem cells back into the patients after the high-dose chemotherapy has been cleared from the body. This Brescues^their blood counts so that the patients recover in approximately 3 weeks from the time of chemotherapy until the time of blood count recovery.
In allogeneic transplantation, rather than collecting the patient's own stem cells, a donor's stem cells are collected instead. This adds the extra benefit of allowing for a graftversus-tumor effect, whereby the newly acquired immune system of the donor attacks the patient's underlying abnormal condition or malignancy. Additional complications of allogeneic transplantation involve the risk of graft-versus-host disease (GVHD). GVHD causes the donor's cells to not only attack the underlying malignancy but the host's regular cells as well (such as the liver, gastrointestinal tract, or skin). To help prevent this, patients are placed on immunosuppressants to weaken the immune response of the donor cells. This also weakens the host immune system, increasing the risk of infection. To prevent infection, patients are placed on prophylactic antimicrobial agents. As a result, patients who undergo HCT are placed on many medications that are required to be taken daily, with numerous associated side effects.
In addition, both autologous and allogeneic HCT patients are at risk for anemia and thrombocytopenia, either from the therapy or related to their underlying condition. Of course, the musculoskeletal system may be affected by deconditioning and steroid myopathy. These issues may be compounded by peripheral neuropathy and psychological/emotional sequalae. Combined, these long-term issues may play a negative role in a patient's quality of life. In particular, fatigue is a significant issue that plagues patients.
All told, one can imagine that patients who undergo HCT have a great deal of stress placed on their bodies. Therefore, it is imperative that they maintain an optimal performance status before transplant, during the initial hospitalization, and through the months, sometimes years, which patients will be managed and followed. In those who undergo the HCT process and those who survive long afterwards, fatigue is a common complaint experienced by patients.
Cancer-related fatigue
Fatigue is the most common and one of the most devastating symptoms among patients with cancer. [2] . According to the National Comprehensive Cancer Network, cancer-related fatigue (CRF) is defined as a Bpersistent, subjective sense of physical, emotional, and/or cognitive exhaustion related to cancer or its treatment that is not proportional to recent activity^ [3] . Fatigue has been rated as having a greater negative impact on quality of life than other cancer-related symptoms such as pain, depression, and nausea [4] . It is important to distinguish so-called healthy fatigue from CRF. Healthy fatigue is fatigue that is eventually relieved by rest and sleep. CRF is not proportional to recent activity and interferes with usual functioning. For example, patients with CRF will complain of difficulty with doing routine activities that previously did not cause any distress, such as laundry, running errands, or cooking. In fact, CRF has a negative impact on all areas of function, including mood, physical function, work performance, social interaction, family care, cognitive performance, school work, and community activities [5] [6] [7] .
Fatigue is also very common among HCT patients. Table 1 reviews the literature on the correlation between fatigue and overall quality of life among survivors of HCT patients. In a study by Gielissen et al., it was estimated that severe fatigue occurs in 35 % of long-term transplant survivors (over 15 years out from transplant). Even in the short term (between 1 and 5 years out from transplant), there is a 41 % chance that severe fatigue occurs [8] . The authors could not conclude that one specific comorbidity caused more fatigue than others-only that comorbidities were in general more often associated with severe fatigue. Additionally, the authors also did not note a correlation between fatigue and hemoglobin level or medications.
The etiology of CRF is not entirely clear, although many potential factors may contribute to this symptom or may be a consequence of this syndrome. Potential factors include direct toxicity from chemotherapy and radiation therapy [30] , the cancer itself [31] , genetic vulnerability [32] , hormonal changes [33] , medication side effects [34] , poor sleep [35] , depression and anxiety [36] , chronic stress, poor nutrition [37], loss of muscle mass and inactivity [38] , and other chronic medical problems [39] . Inflammation related to inflammatory cytokines is increasingly being recognized as playing a key role in the genesis of cancer-related fatigue. Basic research on neural-immune interactions has shown that pro-inflammatory cytokines can cause potent changes in behavior including reduced activity, fatigue, decreased social behavior, and cognitive dysfunction [30] . More debilitating levels of CRF have been associated with increased serum measurements of proinflammatory cytokines [40] . These recent findings may lead one to wonder what factors could be contributing to such fatigue among BMT patients. It may be that inflammation, which in essence is one of the critical factors related to GVHD, may be playing a role. If inflammation is a critical factor in the genesis of CRF, then one would assume that decreasing inflammation may be a key treatment as well.
Exercise in the treatment for cancer-related fatigue
Based on a recent Cochrane Database Systemic review, exercise may be regarded as beneficial for individuals with CRF, particularly during post-cancer therapy [41] . Further research is required to determine the optimal type, intensity, and timing of exercise intervention for mitigating CRF. Nevertheless, exercise has demonstrated significant improvements in multiple areas related to quality of life in addition to fatigue, including mood, bone health, sleep, body composition, functional capacity, and possibly survival among certain cancer survivors, including breast and colon.
Moreover, exercise has also demonstrated physiological and psychological improvement for HCT patients. For example, it has been shown that exercise improves physiologic outcomes after HCT [42] . Exercise has also been shown to reduce fatigue and some musculoskeletal symptoms in survivors [43, 44] . Lower performance status at the time of HCT has been associated with a lower survival and risk for GVHD [45] . Recently, there was a report of the benefits of exercise in mice that had undergone stem cell transplantation [46] . Despite the known benefits of exercise for cancer survivors, unfortunately an assessment of pre-diagnosis level of activity occurs in less than half of cancer survivors.
Pathophysiology of exercise's benefits
As discussed earlier, inflammation is believed to be a key contributor to CRF. In addition, exercise has been shown to decrease fatigue. The mechanism by which exercise decreases fatigue among cancer survivors has not yet been fully elucidated. However, a theoretical model for why exercise may serve as an important tool for CRF may be gleaned from recent developments from the general (i.e., non-cancer) exercise physiology literature. Table 2 presents a summary of the current literature assessing the role of physical rehabilitation and the effect on fatigue and quality of life in HCT.
Exercise has potent anti-inflammatory properties. There are several mechanisms by which this is believed to take place:
1. Exercise reduces visceral fat (i.e., Bbad^fat). An increase in visceral fat is correlated with a higher production of pro-inflammatory cytokines such as TNF, IL-6, and leptin. For this reason, visceral fat is associated with increased all-cause mortality and the development of diabetes, cardiovascular disease, and dementia as well as several cancers [61, 62] . Regular exercise can reduce waist circumference and reduce visceral fat-even in the absence of body weight reduction [63] . 2. Exercise releases IL-6 from contracting muscle. Typically, IL-6 is associated as being a pro-inflammatory cytokine. However, the role of IL-6 may depend on the source where it is being produced. With exercise, the transient rise in IL-6 from muscle during exercise then leads to a subsequent rise in anti-inflammatory cytokines, such as IL-10 and IL-1 receptor antagonist [64] . 3. Exercise increases the secretion of adrenal hormones such as cortisol, epinephrine, and norepinephrine, which have potent anti-inflammatory effects [65] . 4. Exercise changes the phenotype of fat cells to produce less inflammation. M1-type macrophages are associated with the production of inflammatory cytokines and obesity [66] . With consistent exercise, there is a phenotypic switch of adipose tissue macrophages toward M2-type macrophages which produce anti-inflammatory cytokines. 5. Exercise may reduce inflammation via downregulation of toll-like receptors on monocytes and macrophages [67] . Activation of toll-like receptors results in increased production of pro-inflammatory cytokines. Other mechanisms are also believed to play a role in the antiinflammatory effects of exercise.
We do not yet know the relative importance to each of these different anti-inflammatory mechanisms. However, the antiinflammatory effects of exercise may explain why exercise is beneficial for CRF. These anti-inflammatory effects of exercise have generally not been well-studied in the cancer and palliative care setting. More studies are needed to address the optimal prescription of exercise to treat common cancer symptoms. This research includes studies assessing the type of exercise, frequency, duration, and intensity of the exercise, particularly in the setting of HCT recipients.
HCT rehabilitation programs
HCT patients can suffer from a multitude of complications which can have functional and medical consequences. A challenge is finding a way to successfully integrate rehabilitation in the setting of these medical complexities. From a systemsbased approach, the rehabilitation of HCT patients can be N=12; auto only -Design: prospective intervention; 2 arms divided into pre-transplant, peri-transplant, immediately posttransplant, and long-term survivors.
Pre-transplantation rehabilitation of the HCT patient
Many patients have had a significant decline in activity even before the transplant due to prior chemotherapy, radiation therapy, surgery, or other medical complications. Pre-transplant rehabilitation is important because a minimum level of performance may be required before transplant. Also, theoretically improving strength and cardiorespiratory reserves may benefit the patient after the transplant. These pre-transplant rehabilitation concepts have gone by several names including Bpreventative rehabilitation,^Bprehabilitation,^and Bbuffering^ [49, 68, 69] . An example of this concept would be a pre-HCT boot camp. Just as a military boot camp prepares soldiers to endure the challenges of combat, a pre-HCT boot camp could improve strength and cardiorespiratory reserves to prepare patients for HCT. Challenges to the boot camp model include minimizing delays in transplantation and patient tolerance of exercise programs. Additionally, recent research has found that peri-transplant exercise program can be feasible and effective in improving aerobic capacity and strength [50, 70] .
Immediately post-transplant rehabilitation
Post-HCT physical activity drops significantly when compared to pre-HCT physical activity [28] . This may be precipitated by factors such as fatigue. Also, the natural limitations of undergoing intense therapy in a hospital such as continuous connections to IVs, the need for close monitoring and observation of sophisticated infusions, and the limits of isolation due to neutropenic and contact precautions. Rehabilitation during this immediately post-transplant period involves maintaining function, reducing symptom burden, maintaining muscle mass, reducing the risk for pneumonia and atelectasis, and improving aerobic capacity. A typical post-HCT performance pattern is significant functional decline during and immediately after HCT followed by limited improvement [70] . It has also been found that HCT patients have a decline in voluntarily engaging in exercise activities [50] . Reduced exercise activity will exacerbate reduced functional performance. In the post-transplant setting, murine models show that exercise is important because it may impact survival [71] .
Research suggests that structured exercise programs beyond simple encouragement are more effective in maintaining patient activity [49] . Post-HCT exercise/activity may incorporate group exercise programs, an intermittently supervised exercise program, keeping records of distance walked, and frequent individual physical/occupational therapy if indicated.
A physiatrist, also known as a physician who specialized in physical medicine and rehabilitation, helps restore optimal functional and quality of life to patients who have challenges -Fever >38°C -Severe pain -Nausea -Dizziness -Platelets <10,000/μl -Hgb <8 g/dL
Allo allogeneic, Auto autologous, BFI Brief Fatigue Inventory, CARES Cancer Rehabilitation Evaluation System, CG control group, EORTC-QLQ European Organization for Research and Treatment of Cancer Quality of Life Questionnaire, FACT Functional Assessment of Cancer Therapy, Hgb hemoglobin, HRmax heart rate max, HRR heart rate reserve, PA physical activity, QOL quality of life, SOC standard of care, TG training group, VT ventilatory threshold in this arena as a result of illness or injury. A subspecialty of cancer rehabilitation (or onco-physiatry) is also emerging for physiatrists who have a special interest and skill set in the care of patients with cancer, including with problems such as cancer-related fatigue, cancer pain syndromes, and neuromusculoskeletal complications of cancer and its treatment. The central tenet of cancer rehabilitation is to help a person with cancer attain the maximal physical, social, psychological, and vocational functioning within the limits imposed by the disease and its treatment [72] . The Mayo Clinic developed a physiatry consult-based cancer rehabilitation model published in 1980. The cancer adaptation team (CAT) consisted of a physiatrist, physical therapist, occupational therapist, nurse, social worker, and chaplain. The team held daily meetings regarding patients and followed the patients while they were on the primary oncology service. Although there was no control group, they published results demonstrating improvements in the Karnofsky and Barthel Index scores of their patients [73, 74] . The CAT model is still being used at the Mayo Clinic today. At MD Anderson Cancer Center, a similar model called the mobile team has been used for several years. The mobile team consists of a physiatrist, physical therapist, occupational therapist, and nurse and also involves daily morning meetings to discuss patient cases. The mobile team can be thought of as mobile acute inpatient rehabilitation. Patients rehabilitate with the mobile team while on the primary acute care service. Mobile team patients can receive up to 1 h of physical therapy and up to 1 h of occupational therapy daily depending on their therapy tolerance (so up to 2 h of therapy/day, this is in contrast to the 3 h of therapy/day in acute inpatient rehabilitation). The goals of the mobile team can vary depending on the patient. One goal of the mobile team is to address therapy tolerance. This information is useful in determining an appropriate rehabilitation destination for the patient. If a patient can tolerate 2 h/day of therapy without issue, it is likely that they could tolerate 3 h/day on acute inpatient rehabilitation. A second common goal for the mobile team is to overcome barriers to discharging the patient home such as family training, educating on the use of equipment, stair training, or how to transfer. The more intense therapy of the mobile team (versus the typical floor therapists) often times can achieve these goals while remaining on the primary acute care team. If successful, it may enable the patient to discharge home without transferring to another rehabilitation setting. It is also more efficient because patients can begin more intense rehabilitation while still on the acute care medical team's service. The CAT and mobile team are not used exclusively for HCT patients; however, they are very useful in this population given their medical fragility. Due to reimbursement models, the increased therapy provided to HCT patients in the mobile team/cancer adaptation team model may be cost-prohibitive in diagnosis-related group health care facilities.
Intermittently supervised exercise programs are used at many institutions where HCTs occur. However, the evidence is not yet clear about the most beneficial type or timing of exercise as an adjuvant intervention for patients on the HCT continuum [60] . At MD Anderson, it starts with patient education (pre-transplant preferred) regarding guidelines for exercise precautions including education on fatigue, orthostasis, and other complications. During the HCT hospitalization, patients undergo a self-performed exercise program, pedal exerciser, and frequent follow-up with a therapist who performs individual therapy with the patient. Group sessions also occur several times a week and are with a physical therapist, occupational therapist, or music therapist. In hospitals where development of large specialized teams for implementation of physical rehabilitation programing is out of reach, other smaller scale strategies may be used. Providing patients with handouts about the benefits of exercise and physical activity prior to HCT, connecting patients with community support programs at local fitness centers and cancer support programs after HCT, and designing a basic home-based exercise program for patients during the HCT continuum are feasible, inexpensive, and effective modes for delivering physical rehabilitation (and prehabilitation) to HCT patients. Table 3 provides example guidelines that could be given to HCT patients as part of a cancer rehabilitation program.
During the post-transplant period, patients cannot remain on the acute care service indefinitely. If the patient is unable to safely discharge home, a transfer to another rehabilitation setting may be required. This can present a challenging situation because of this patient population's medical fragility. One study showed that 41 % (61/147) of HCT inpatient rehabilitation admissions were transferred back to the primary acute care service [75] . Of those (18 %) , cardiac issues (10 %), mental status changes (10 %), gastrointestinal bleeding (7 %), completion of rehabilitation (3 %), brain hemorrhage (3 %), and leukemia treatment or recurrence (3 %). Significant or near-significant relationships were found for platelet counts less than 43,000/mL (p < .01), creatinine greater than 0.9 mg/dL (p<.01), the presence of an antiviral agent (p = .0501), the presence of an antibacterial agent (p =.0519), the presence of an antifungal agent (p<.05), and a leukemia, lymphoma, or multiple myeloma diagnosis (p<.05). From this, a return to primary-bone marrow transplant scoring system (RTP-BMT) was developed. The RTP-BMT score is shown in Table 4 . Future validation studies of the RTP-BMT score are needed. However, the RTP-BMT score could be useful to a physiatrist who is determining the best rehabilitation destination for a HCT patient. Patients with a high RTP-BMT score may benefit more from in-house rehabilitation where they are close to medical resources for acutely ill patients. Patients with a lower RTP-BMT score may be safe to transfer to an outside rehabilitation facility. Outside rehabilitation facilities are often freestanding and can be miles from the nearest intensive care unit or medical specialists. At skilled nursing facilities, patients are not typically seen daily by a physician. Transferring patients at high risk for medical complications to such facilities may create a dangerous situation for the patient. Platelet count LESS than 43,000 per microliter (μL)=1; 43 K/uL or GREATER=0
Creatinine GREATER than .9 (milligram/deciliter, mg/dL)=1; .9 mg/dL or LESS=0
RTP-BMT return to primary-bone marrow transplant index
The long-term HCT survivor
Cancer survivorship care continues to increase and is an area of tremendous growth in cancer rehabilitation. As time passes, the focus of these patients shifts from simply surviving the cancer to quality of life. Many long-term post-HCT cancer survivors suffer from impairments due to treatments and complications they received as demonstrated in Fig. 1 . The bad news is that peripheral neuropathy, steroid myopathy, chronic fatigue, deconditioning, and lost muscle mass are common issues in this patient population. The good news is that many of these issues can be addressed by physiatry and rehabilitation. The long-term HCT survivor's rehabilitation will likely occur in an outpatient setting and may require months, years, or longer. Some patients will not be able to return to work and may require assistance applying for disability.
Despite an increased recognition of the importance of cancer rehabilitation and hematopoietic stem cell transplantation, barriers continue to exist. Unfortunately, physical medicine and rehabilitation is unavailable in many cancer centers [76] . When it is available, cancer rehabilitation is often underutilized due to a lack of awareness of its role and potential benefits [77] [78] [79] . Educating oncologists and other cancer health care professionals about the presence and capabilities of cancer rehabilitation is important.
The role of psycho-oncology and physiatry in HCT rehabilitation
The psychological aspects of survivorship must also be factored in, and mental rehabilitation may need to be focuses on. Psycho-oncology represents an area of multi-disciplinary interest (psychiatry, psychology, social worker, spiritual care, nursing, etc.) whose goals is to holistically improve the care of people affected by cancer and its treatment at all stages. Psycho-oncologists are also best equipped to evaluate the psychological, social, and behavioral factors that influence tumor progression and survival. As such, psycho-oncology would be an ideal and integral part of the rehabilitation team for patients undergoing SCT, when available, given the profound psychological and behavioral implications of this treatment process.
Conclusion
One of the key reasons for the improvement in quality of life and overall survival in HCT patients has been the significant progress made in the supportive care of such patients. In particular, strides in rehabilitating patients physically, with a focus on inflammation, fatigue, and exercise, will hopefully continue to improve patient lives. Rehabilitation of HCT Fig. 1 Impairments, disabilities, and handicaps of long-term HCT survivors patients can occur using a variety of models during the pretransplant, immediately post-transplant, and long-term posttransplant phases.
